The pulmonary adenoma susceptibility 1 (Pas1) locus affects inherited predisposition and resistance to chemically induced lung tumorigenesis in mice. The A/J and C57BL/6J mouse strains carry the susceptibility and resistance allele, respectively. We identified and genotyped 65 polymorphisms in the Pas1 locus region in 29 mouse inbred strains, and delimited the Pas1 locus to a minimal region of 468 kb containing six genes. That region defined a core Pas1 haplotype with 42 tightly linked markers, including intragenic polymorphisms in five genes (Bcat1, Lrmp, Las1, Ghiso, and Kras2) and aminoacid changes in three genes (Lrmp, Las1, Lmna-rs1). In (A/J Â C57BL/6J)F1 mouse lung tumors, the Lmna-rs1 gene was completely downregulated, whereas allelespecific downregulation of the C57BL/6J-derived allele was observed at the Las1 gene, suggesting the potential role of these genes in tumor suppression. These results indicate a complex multigenic nature of the Pas1 locus, and point to a functional role for both intronic and exonic polymorphisms of the six genes of the Pas1 haplotype in lung tumor susceptibility.
Introduction
Mouse inbred strains show wide variation in their inherited predisposition or resistance to chemically induced lung tumorigenesis (Malkinson, 1989) . Genetic linkage studies have mapped several pulmonary adenoma susceptibility (Pas), resistance (Par), and progression (Papg1) loci, as well as epistatic loci in mice (see review in Dragani, 2003) . Among these lung cancer modifier loci, the Pulmonary adenoma susceptibility 1 (Pas1) locus, mapping in the distal region of Chromosome 6, appears to play a major role in the genetic predisposition to lung cancer. Indeed, the Pas1 locus explained a high proportion of the genetic variance of lung tumor phenotypes (Gariboldi et al., 1993) , and has been confirmed in independent crosses and laboratories (Devereux et al., 1994; Festing et al., 1994) .
Identification of Pas1 candidate genes by positional cloning requires the reduction of the mapping region to a manageable size. After the first mapping studies that placed the Pas1 locus in a 10-20 cM interval (Gariboldi et al., 1993) , linkage disequilibrium (LD) analysis in mouse inbred strains of known susceptibility/resistance to urethane-induced lung tumorigenesis placed the Pas1 locus in a B1.5-Mb region (Manenti et al., 1999) . Subsequent LD analysis of outbred mouse lines susceptible and resistant to both inflammatory response and lung tumorigenesis delineated a 0.45-Mb region around the Kras2 gene, included in the previous 1.5-Mb region (Maria et al., 2003) . The 0.45-Mb region includes Lrmp gene polymorphisms, which showed significant LD in the lines and thus represented an obvious Pas1 candidate gene (Maria et al., 2003) .
A recent study used A/J Â C57BL/6 advanced intercross lines (AIL) to shorten the Pas1 locus interval, but it provided no advantage over LD analysis, since it suggested placement of the Pas1 locus in a 1.3-Mb interval that includes the previous 0.45-Mb LD region and B27 known or predicted genes . Analysis of A/J Â C57BL/6 congenic strains narrowed the Pas1 locus interval to a 0.5-Mb region containing 12 putative genes (Zhang et al., 2003) . Six of these 12 genes, chosen on the basis of mRNA expression in lungs, have been analysed for coding polymorphisms and in vitro allelic effects; five of the six genes showed no allelicspecific effects in vitro and their candidacy was excluded, whereas the sixth gene, Las1, showed allelic-specific effects in vitro and in a tumor growth assay in nude mice, and was proposed as the candidate Pas1 gene (Zhang et al., 2003) . However, that study cannot be considered conclusive since the other five expressed genes in the interval might also modulate lung tumorigenesis by mechanisms other than those affecting tumor growth (Hanahan and Weinberg, 2000) . Among these genes, Lrmp, Bcat1, and Kras2 have been associated with inflammatory response, apoptosis, and tumor development (Eden and Benvenisty, 1999; Johnson et al., 2001; Maria et al., 2003) . There is also growing evidence that several quantitative trait loci (QTLs) are constituted by a cluster of genes with related functions (Cormier et al., 2000; Darvasi and Pisante-Shalom, 2002; Steinmetz et al., 2002) .
In the present study, we tested the polymorphisms in the Pas1 locus region in a population of 29 laboratory mouse inbred strains by high-density haplotype and gene expression analyses. We detected a shared A/J-and C57BL/6J-type haplotype containing genomic and coding polymorphisms in six genes, supporting the hypothesis that Pas1 is a multigene locus. Two of these genes, Las1 and Lmna-rs1, showed either allele-specific mRNA expression or complete silencing in tumors.
Results

Physical delimitation of the Pas1 locus telomeric boundary
Genotyping of 33 markers on Chromosome 6 confirmed that the CXB5 (also called CXB I) RI mouse line inherited almost all of Chromosome 6 from the Pas1-susceptible BALB/c parental strain (not shown). However, this line is highly resistant to lung tumorigenesis, developing 0.07 tumors per mouse after urethane treatment (Malkinson and Beer, 1984) . This observation can be explained by the presence of a small recombination in the BALB/c-derived genome, with insertion of a C57BL/6J-derived fragment that includes the Pas1 locus. We located the centromeric point of recombination between markers D6Mit198 and D6Int152 (an SSLP mapping at 142.931580 Mb). The telomeric end of recombination was localized in a 9.9-kb fragment between markers D6Int47 (145.814802 Mb) and D6Int56 ( Figure 1 ). D6Int47 is located in the middle of exon 4 of the 4933403M22Rik gene, whereas D6Int56 is located in the intronic region between exons 2 and 3 of the same gene.
Identification of a core Pas1 haplotype
Nucleotide sequence of B20 000 bp of the Pas1 region allowed to identify 194 SNPs/SSLPs between A/J and C57BL/6J mice. In all, 65 of these genetic markers were genotyped in 29 mouse inbred strains. This approach allowed us to identify a 468-kb region (from D6Int24 to D6Int47) containing a shared Pas1 haplotype characterized by two main types: an A/J and a C57BL/6J type ( Figure 2 ).
Of 54 markers of the Pas1 haplotype, 42 (78%) showed perfect segregation with the haplotype, that is, no strain of the A/J type carried a C57BL/6J-type polymorphism and vice versa (Figure 2 , boxed markers). The perfect segregant markers included both coding (see below) and noncoding polymorphisms; the latter were located either in the intragenic or intergenic regions of six genes mapping in the haplotype (Figure 2 ).
According to the Ensembl database, five known genes map in this 468-kb region: the branched-chain aminotransferase cytosolic 1 (Bcat1), the lymphoidrestricted membrane protein (Lrmp), the unnamed 4930469P12Rik transcript, the transforming protein p21 (Kras2), and the unnamed 4933403M22Rik transcript. Protein sequence comparison by BLAST showed that the 4933403M22Rik gene encodes a protein containing an intermediate filament tail domain related to lamin A. Therefore, the 4933403M22Rik gene was provisionally named Lmna-rs1 (lamin A-related (Figures 1, 2) . The 4930469P12Rik gene encodes a growth hormone-inducible soluble protein (AF412299) with no known protein domains; the gene was provisionally named Ghiso (growth hormoneinducible soluble protein) (Figures 1, 2) . Using different programs to identify coding regions in the genome (NIX analysis package), we identified and then cloned a previously uncharacterized gene mapping between Lrmp and Ghiso. This gene is the mouse homolog of the human AK001783 transcript and corresponds to the recently identified Las1 gene (Zhang et al., 2003) , except for an additional 70 bp in the 5 0 -UTR. This new gene has 16 exons, spans a 36-kb region, and is flanked at its 3 0 -end by the 3 0 -end of Lrmp and at its 5 0 -end by the 5 0 -end of Ghiso (Figure 1 ). The upstream intragenic regions of both Las1 and Ghiso genes consist of a common 176-bp genomic fragment that, in light of its short length and the flanking of the 5 0 -ends of two genes, might share a bidirectional promoter activity.
Lrmp, Las1, Ghiso, and Lmna-rs1 genes showed nucleotide polymorphisms between A/J and C57BL/6J mice that produced amino-acid changes. Coding polymorphisms tightly linked with the Pas1 haplotype included a D56G polymorphism (D6Int32a) in exon 3 of Lrmp, a L537P polymorphism (D6Int8) in exon 18 of Lrmp, a S60N polymorphism (D6Int41) in exon 4 of Las1, a silent Q278Q polymorphism (D6Int38) in exon 9 of Las1, a E258G polymorphism (D6Int46) in exon 5 of Lmna-rs1, and a H218S polymorphism (D6Int47) in exon 4 of Lmna-rs1; additional amino-acid changes were not linked with the Pas1 haplotype (D6Int4 and 
Allele-specific expression of Las1 gene in mouse lung tumors
Expression analysis of the six candidate genes Bcat1, Lrmp, Las1, Kras2, Ghiso, and Lmna-rs1 was carried out in four normal lungs of A/J and C57BL/6J mice, in five non-affected surrounding lung parenchyma of AB6F1 mice, and in nine urethane-induced lung tumors (3-5 mm in diameter) of AB6F1 hybrids. Semiquantitative RT-PCR revealed expression of all the six genes at similar levels in the normal mouse lung of A/J, C57BL/ 6J, and AB6F1 mice (not shown), whereas in lung tumors, Bcat1, Lrmp, Kras2, Las1, and Ghiso, but not Lmna-rs (Figure 3 ), were expressed. Transcript levels were similar in normal and tumor samples for Bcat1, Las1, Kras2, and Ghiso genes; Lrmp showed a slightly reduced expression (about twofold) in six of nine tumors (not shown).
Allele-specific expression patterns of Lrmp, Ghiso, Las1, and Kras2 genes were analysed in normal lungs and tumors from AB6F1 hybrids. No allelic differences in the expression of Lrmp and Ghiso were detected in normal lungs or tumors of these mice. Expression of both Las1 alleles was detected in the normal lungs, but mono-allelic expression of the 60N allele deriving from the A/J lung tumor-susceptible parent was found in all tumor samples analysed for the S60N polymorphism in exon 4 (D6Int41) (Figure 4 ), suggesting allele-specific silencing/activation of the Las1 gene in lung tumors. Analysis of Kras2 allele expression using the herein identified D6Int142 SNP (A145635211G, Tyr32Tyr) (Acc. #AY490389) polymorphism located in exon 1 of this gene revealed a slightly preferential expression of the A/J as compared to the C57BL/6J allele (2-3-fold ratio) in the nine tumor samples (not shown). All tumors carried a codon 61 Kras2 mutation (CAA-CTA in 5/9 tumors and CAA-CGA in the remaining four tumors), but the mutated allele was expressed at heterozygosity in all tumors, with about 1 : 1 ratio of the wild type to the mutated allele ( Figure 5 ).
Discussion
In the present study, a high-density Pas1 haplotype map was constructed by identifying and genotyping 54 markers in a 468-kb region in 29 inbred strains. This analysis led to the identification of a conserved core haplotype in the Pas1 locus region. The boundaries of the Pas1 core haplotype were physically defined by the decay of its association to alleles at o145.346 Mb (D6Int24) and at 4145.815 Mb (D6Int47) from the Chromosome 6 centromere (Figure 1 ). The distal boundary of the Pas1 locus was also defined by a Six genes were contained in the Pas1 core haplotype; thus, the power of our haplotype analysis in inbred strains was higher than AIL (27 genes) or congenic (12 genes) restrictions of the region Zhang et al., 2003) . The haplotype of the Pas1 region defined strain relatedness in which the laboratory strains resolved as two groups according to the A/J-and the C57BL/6J-type haplotype, respectively. This finding confirmed that the Pas1 QTL is due to an ancestral difference common to many laboratory strains rather than to a rare mutation specific to a single strain (Manenti et al., 1999) .
Recent studies indicate that regions of low SNP density (B0.5 SNPs per 10 kb) are separated by regions of high density (B40 SNPs per 10 kb), creating a mosaic structure of genetic variations in mice and defining haplotype blocks of an average size of 1 Mb (Wade et al., 2002; Wiltshire et al., 2003) . Laboratory strain haplotypes recapitulate the population history of these strains and identify strain relatedness (Wiltshire et al., 2003) . However, the Pas1 core haplotype showed a high-density polymorphism ratio (B100 SNPs/SSLPs per 10 kb), but resulted in only two haplotype types. The Pas1-derived strain grouping was very different from that defined by wholegenome analysis of SNPs in mouse strains, which reflects strain genealogy (Wiltshire et al., 2003) . Indeed, unlike the strain relatedness of the Pas1 locus, whole-genome SNP analysis placed strains carrying the A/J-and C57BL/6J-type haplotype at the Pas1 locus close together (see Figure 4d of Wiltshire et al. (2003) , where RF/J and AKR/J, CBA/J and C3H, SWR/J and SJL/J strains are placed in the same sub-branches). Therefore, the Pas1 haplotype is not the product of strain genealogy.
In addition, 12/54 (22%) markers located within the haplotype did not cosegregate with the haplotype (Figure 2 ), suggesting that recombination had taken place during the creation of the haplotype block and that LD between the haplotype and nonessential polymorphisms has been lost. The nonlinked polymorphisms also included two polymorphisms (D6Int4 and D6Int10) causing an amino-acid change in the Lrmp and Ghiso gene, respectively, and two silent polymorphisms in the coding region of the Lrmp (D6Int32c, Acc. #AY490382) and Kras2 gene (D6Int142, Acc. #AY490389) (Figure 2) .
Within the haplotype block, five amino-acid changes in three genes showed a tight linkage with the haplotype (Figure 2 ): D6Int32a: D56G in the Lrmp gene, D6Int8: L537P in the Lrmp gene, D6Int41: S60N in the Las1 gene, D6Int46: E258G in the Lmna-rs1 gene, and D6Int47: H218S in the Lmna-rs1 gene. These polymorphisms produced nonconservative changes. However, the effect of any polymorphism on protein function relies not only on the type of change, but also on where the change occurs. For example, a change in a substrate binding site domain seems more likely to affect protein biochemical activity than a change in a noncritical domain. In any case, the prediction of a functional effect of any amino-acid change awaits experimental evidence to identify the relevant variations among the thousands of genetic variations identified so far with the knowledge of the mouse and human genomes.
As the amino-acid polymorphisms of three genes (Lrmp, Las1, and Lmna-rs1), as well as intragenic polymorphisms of the Bcat1, Ghiso, and Kras2 genes, are tightly linked in a single haplotype type (Figure 2) , we cannot exclude any of these six genes as putative Pas1 candidate genes. Moreover, seven intergenic and 29 intragenic polymorphisms showed a tight linkage with the Pas1 haplotype (Figure 2 ). The tight linkage of genomic polymorphisms also points to a functional role for these polymorphisms. Indeed, Bcat1, Las1, Kras2, and Lmna-rs1 genes show a complex mRNA isoform pattern (not shown), whose regulation may rest on intronic or promoter variations, as reported for other genes (Webb et al., 2003) . Genetic variations in regulatory regions of the genes have been shown to play a functional role in gene expression or translation, and also to constitute the functional polymorphisms of QTLs (Kawakami et al., 2001; Liang et al., 2003) . A strong LD was observed between genetic variations in the Drosophila dopa decarboxylase gene, and both coding and regulatory polymorphisms constituted haplotypes associated with variation in longevity (De Luca et al., 2003) .
The present results suggest that the Pas1 locus is comprised of a cluster of six cancer modifier genes, whose amino-acid and genomic polymorphisms operate to confer susceptibility or resistance to lung tumorigenesis. Observations in other models suggest or demonstrate that the functional activities of several QTLs are mediated by a cluster of genes with related functions (Cormier et al., 2000; Darvasi and Pisante-Shalom, 2002; Steinmetz et al., 2002) .
Recently, the Las1 gene has been proposed as the Pas1 gene based on the presence of an amino-acid variation in the encoded protein between the A/J and C57BL/6J strains, on allele-specific modulation in clonogenic assay in vitro of transfected mouse lung tumor cells, and on growth in nude mice of the same transfected cells (Zhang et al., 2003) . However, the authors did not report the growth rate of nontransfected or vector-transfected control cells in nude mice, so that the magnitude of the stimulatory or inhibitory effects of the Las1 alleles on tumor growth remains unclear. Obviously, in vitro assays cannot detect all possible gene effects on tumorigenesis, which is a complex phenomenon involving tumor-host interactions that are modulated by numerous factors (Hanahan and Weinberg, 2000) . Moreover, in that study (Zhang et al., 2003) , genetic recombination did not separate the Las1 gene from the other five genes of the herein identified Pas1 haplotype, confirming our hypothesis that none of the Pas1 locus in inbred strains G Manenti et al six genes can yet be formally excluded from Pas1 candidacy.
On the other hand, we identified the same N60S polymorphism in the Las1 gene and found its tight linkage with the Pas1 haplotype in inbred strains, in agreement with the proposed candidacy of this gene for Pas1 locus activity. Our Las1 transcript (Acc. #AY485607, AY485608), as compared to the AY423542 transcript, is 70 bp longer in the 5 0 -UTR, most likely representing the full-length transcript of the gene. Analysis of the putative secondary structure of the Las1 encoded protein predicted a coiled-coil domain in its N-terminal region (amino acids 9-59) (http:// www.ch.embnet.org/software/COILS_form.html). The coiled-coil structure is one of the principal oligomerization motifs in proteins (Burkhard et al., 2001) . Interestingly, the Las1 gene showed expression of both alleles in normal lungs of AB6F1 mice, but only the A/J-derived allele in tumors (Figure 4) . These results provide evidence of tumor allele-specific silencing/activation of Las1.
Among the other putative Pas1 candidate genes in the haplotype, Bcat1 catalyses the first step of branchedchain amino-acid catabolism, is a direct target for c-myc regulation, and is involved in apoptosis (Eden and Benvenisty, 1999) . The Lrmp gene encodes a protein (Jaw1) with a coiled-coil domain in the middle-third of the protein and a carboxyl-terminal membrane anchor (Behrens et al., 1994) . Since the Las1 encoded protein also carries a coiled-coil domain, the two proteins may either interact each other or with a common substrate.
Lrmp expression was originally described as lymphoid cell-specific, with highest expression levels in pre-T, pre-B, and mature B cells (Behrens et al., 1994) . However, we detected significant Lrmp expression levels in lung tumors (not shown); clarification of whether Lrmp expression occurs in normal epithelial lung cells or is instead restricted to lung-associated lymphoid cells awaits immunohistochemical analysis of normal lung. The Jaw1-homologous protein Mrvil, mapping on Chromosome 7, causes leukemia in mice upon activation by retroviral integration (Shaughnessy Jr et al., 1999) , suggesting an important role for this class of integral membrane proteins in cancer and, possibly, for Lrmp polymorphisms in lung cancer susceptibility. A role for lymphoid cells and, more widely, of the immune system in lung tumorigenesis is suggested by enhancement of lung adenoma formation in neonatally thymectomized mice treated with 7,12-dimethylbenz(a)anthracene or urethane (Trainin et al., 1967) . Moreover, splenectomy inhibited DMBA-induced lung tumor incidence in mice (Akamatsu, 1975) , and inflammation is a known modulator of tumor development, both in mice and humans (Askling et al., 1999; Mayne et al., 1999; Brownson and Alavanja, 2000; Bauer et al., 2001) . The D6Int8 polymorphism in the Lrmp gene (L537P) segregates with both the Pas1 haplotype and the inflammatory response susceptibility in mouse lines phenotypically selected for high and low acute inflammatory responses (Maria et al., 2003) .
Kras2 is causally linked with lung tumorigenesis, since somatic mutations of this gene cause lung tumor development . Genomic Kras2 polymorphisms might modulate gene mutability and, in turns, numbers of tumors after chemical carcinogen treatment. The functional involvement of Kras2 in lung tumorigenesis has been demonstrated for its wild-type (Zhang et al., 2001) and mutated alleles, which we found expressed at an almost perfect 1 : 1 ratio in lung tumors (Figure 5 ), in contrast with the reported loss of heterozygosity of the wild-type Kras2 allele in mouse lung tumors (Zhang et al., 2001) . The role of Kras2 preferential allele expression remains to be elucidated, but may involve genomic polymorphisms of the region that also control Las1 allele-specific expression in lung tumors. Transgenic mice in which the A/J-derived Kras2 gene (introns and exons) is inserted in the germ line of C57BL/6J mice would be useful in addressing the role of Kras2 genetic polymorphisms in modulation of lung tumor susceptibility (Pas1 activity).
No expression of the Lmna-rs1 gene was detected in lung tumors (Figure 3) , analogous to the downregulation of the retinoblastoma (Rb) gene (Re et al., 1992) , raising the possibility that Lmna-rs1 represents a putative new tumor suppressor gene. Alternatively, Lmna-rs1 may be a cell-type differentiation marker, whose expression is restricted to specific lung cell types that do not give rise to lung tumors.
Dissection of the specific gene functions within the Pas1 haplotype might require the generation of complex transgenic or knock-in mice, in which genomic regions of one Pas1 haplotype type are inserted into the genetic background of the other haplotype type. An approach such as that used to generate a transgenic mouse by germ-line insertion of a cosmid containing the entire Pla2g2a gene for testing its candidacy for the Mom1 locus (Cormier et al., 1997) might be more suitable than using cDNA constructs for transgenic generation to test Pas1 candidate genes. Understanding the biochemical and biological functions of each of the genes will help to explain the reasons for the inheritance of the haplotype block. Detailed genetic analysis of the homologous human region in lung adenocarcinoma patients and healthy population controls might determine whether specific haplotypes also occur in humans and whether they control lung cancer risk.
Materials and methods
Mouse strains and DNAs
A panel of 29 genomic DNAs from mouse inbred strains, plus DNAs of 13 CXB RI lines were purchased from The Jackson Laboratory (Bar Harbor, ME, USA). C57BL/6J and A/J mice were also from The Jackson Laboratory.
Lung tumor induction
F1 hybrids (ABF1) of male C57BL/6J and female A/J crosses were treated intraperitoneally at 4 weeks of age with urethane (BDH, Poole, UK) dissolved in water (1000 mg/kg body weight) as described (Manenti et al., 2002) and observed until 50-60 weeks of age, when mice were killed. Normal lungs from untreated A/J and C57BL/6J male mice of about 6 months of age were used for RNA preparation. Lung tumors and normal lung tissue were excised, immersed in RNAlater (Qiagen, Valencia, CA, USA) and maintained at À201C.
Identification and analysis of genetic variations
In A/J and C57BL/6J mice, we carried out nucleotide sequence analysis of genomic fragments for a total length of about 20 000 bp in the region of mouse Chromosome 6 spanning D6Int20 to D6Int45, corresponding to the region from 145.027489 to 146.035280 Mb according to Ensembl Mouse release 13.30.1 (http://www.ensembl.org/).
In all, 65 genetic markers were used in genotyping 29 inbred strains. Among the 65 markers, 14 SSLPs and three SNPs have been described (Manenti et al., 1999; Maria et al., 2003) . The remaining 48 markers (D6Int24-D6Int146, see details in Tables  1, 2 ) were newly developed as described (Maria et al., 2003) . All PCR primers used in this study were designed using the Primer 3 software (http://www.genome.wi.mit.edu) and purchased from MWG Biotech, Ltd (Ebersberg, Germany). To generate new SNPs, the nucleotide sequence of the chromosomal region was analysed by the NIX program (http:// www.hgmp.mrc.ac.uk/Registered/Webapp/nix/) to identify putative exons. PCR primers were designed in the genomic (Manenti et al., 1999) or by direct sequencing, whereas SSLPs were analysed by polyacrylamide gel electrophoresis (Manenti et al., 1999) .
Fine-mapping recombination breakpoint in CXB RI line
The genotypes of the distal region of Chromosome 6 of CXB RI strains (http://www.informatics. jax.org) were retyped for confirmation and compared with the lung tumor susceptibility data of the lines (Malkinson and Beer, 1984) . The CXB5 RI line was genotyped using 33 markers flanking the Pas1 region, in order to precisely define the extension of the C57BL/6J-inherited genome around the Kras2 gene. Among these 33 markers, 12 were constituted by MIT SSLPs, and the remaining 21 markers were developed as described above.
Pas1 candidate gene identification
The genomic region between markers D6Int24 and D6Int15 (Pas1 core haplotype) was extensively analysed to identify all putative coding regions based on both homology search and gene prediction programs present in the NIX analysis package. The mRNA sequences of Bcat1 (AK013888), Lrmp (NM_008511), 4930469P12Rik (AF412300), Kras2 (NM_021284), and 4933403M22Rik (AK016641) were retrieved from the Genebank. Computational sequence analysis techniques, BLAST and NIX, were used to assemble the Las1 gene (Acc. #AY485607, AY485608). The accuracy of this prediction was evaluated by PCR analysis of cDNA with primers located in the middle of putative exons. The 5 0 end of the Las1 gene was determined by 5 0 RACE using the SureRACEt panels (OriGene Technologies, Rockville, MD, USA).
The sequences of the six genes were PCR-amplified from normal lung cDNA of A/J and C57BL/6J mice with the following primer sets:
0 -CTCTG CCAGCCATGATGAA-3 0 , 5 0 -TTTCATGGCTTTCCATTTT CTT-3. PCR products from the two mouse strains were sequenced and compared for polymorphism.
Allele-specific expression of candidate genes in mouse lung tumors
Normal and lung tumor samples were lysed in 700 ml of lysing solution using the MM 300 mixer mill (Retsch GmbH & Co., Haan, Germany). Total RNA was extracted according to the RNeasy Midi kit (Qiagen, Valencia, CA, USA) protocol, including a DNase I treatment performed directly on the column.
PolyA þ mRNA was prepared by mixing total RNA with Oligotex suspension (Qiagen, Valencia, CA, USA). Aliquots of polyA þ mRNA were reverse-transcribed using oligo(dT) primers and Superscriptt for RT-PCR (Invitrogen, Carlsbad, CA, USA). The first-strand cDNAs were used for expression analysis of candidate genes by a semiquantitative PCR, adjusting the numbers of PCR cycles to avoid saturation of PCR amplification. All reactions were performed in a final reaction volume of 12 ml containing 1 Â GeneAmp buffer, 1.5 mM MgCl 2 , 5 pmol of each primer, 200 mM of dNTPs, and 0.6 U of AmpliTaq Gold (Applied Biosystems, Foster City, CA, USA). Thermocycling were performed on the Gene Amp PCR System 9700 (Applied Biosystems). Primer sets were designed to obtain a PCR product 170-400 bp in size. The Gapdh gene was amplified with primers 5 0 -TGTT CCTACCCCCAATGTGT-3 0 and 5 0 -GTGGAAGAGTGG GAGTTGCT-3 0 , producing a 179-bp fragment, and used to normalize the amount of cDNA in each sample. Candidate Pas1 genes were RT-PCR-amplified with the following primers: Bcat1, 5 0 -ATTCCAACGATGGAGAATGG-3 0 , 5 0 -TCTTCTGTGGCACCGTCAC-3; Lrmp, 5 0 -ACGCTGAG GACGAGAGAAGT-3 0 , 5 0 -TGCTCTGTTGGCTCTTCT GA-3 0 ; Las1, 5 0 -TGAAGCTGCTGAGTGAAGCA-3, 5 0 -AC TAGCACCCAGCCCTTCAC-3 0 ; 4930469P12Rik (Ghiso), 5 0 -TCATGTATAAAAGTGGATCAATTCC-3 0 , 5 0 -TGGTG CAATGATTGGTCAG-3; Kras2, 5 0 -GGAGAGAGGCCTG CTGAAA-3 0 , 5 0 -ACCATAGGCACATCTTCAG-3; 4933403 M22Rik (Lmna-rs1), 5 0 -CCTATCCACTGGAAGCAAGC-3, 5 0 -TTTCATGGCTTTCCATTTTCTT-3 0 . PCR products were loaded on 2.5% agarose gels, stained with ethidium bromide, and photographed with a CCD camera for image analysis and quantitation.
For allele-specific gene expression, RT-PCR products containing SNPs were sequenced with both the forward and reverse primers. The following primer sets were used: Lrmp, 5 0 -CATCGCTTCATCAGCACCTA-3 0 , 5 0 -CTCA GAAAGGCTGGGCTTC-3 0 ; Las1, 5 0 -GCAGGAGGAG GAGGAGAGAC-3, 5 0 -TGTTCAAAGGCCTGGTTCTT-3 0 ; 4930469P12Rik (Ghiso) 5 0 -TCATGTATAAAAGTGGAT CAATTCC-3 0 , 5 0 -TGGTGCAATGATTGGTCAG-3; Kras2 5 0 -GGAGAGAGGCCTGCTGAAA-3 0 , 5 0 -ACCATAGGCA-CATCTTCAG-3. The same Kras2 primers also allowed detection of Kras2 mutations at codon 61 by nucleotide sequence analysis of the PCR product.
Sequence pherograms were analysed and the heights of peaks at the SNP position were evaluated.
